STOCK TITAN

Asensus Surgical Inc - ASXC STOCK NEWS

Welcome to our dedicated news page for Asensus Surgical (Ticker: ASXC), a resource for investors and traders seeking the latest updates and insights on Asensus Surgical.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Asensus Surgical's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Asensus Surgical's position in the market.

Rhea-AI Summary
Asensus Surgical, Inc. (NYSE American: ASXC) announced the sale of a Senhance® Surgical System to be placed in a hospital in the Commonwealth of Independent States region, marking the second system sold to the region in the past month. Anthony Fernando, President and CEO, expressed excitement about partnering with another institution to deliver better patient outcomes through their advanced digital laparoscopic platform.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.14%
Tags
none
-
Rhea-AI Summary
Asensus Surgical, Inc. (NYSE American: ASXC) announced its operating and financial results for the third quarter 2023. Key highlights include 17% growth in surgical procedures, two Senhance Surgical programs initiated in the quarter, and $33.1 million cash and cash equivalents at September 30, 2023. The company also provided updates on the LUNA Surgical System, market development, and 2023 milestones.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.33%
Tags
-
Rhea-AI Summary
Asensus Surgical, Inc. (ASXC) announced the sale of a Senhance® Surgical System to be placed in a pediatric hospital in the Commonwealth of Independent States (CIS) region. The system's specialized technology aims to reduce invasiveness and enhance precision in pediatric patients, offering potential improvements in patient care.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
14.29%
Tags
none
Rhea-AI Summary
Asensus Surgical, Inc. (NYSE American: ASXC) announces an agreement with Flex (NASDAQ: FLEX) for design and advanced manufacturing services for the LUNA Surgical System, a next-generation surgical robot platform. Flex will provide services to enable Asensus Surgical to deliver the platform at scale, faster, including design for manufacturing services and a trusted supply chain network. Asensus Surgical President and CEO, Anthony Fernando, emphasizes the potential of LUNA to revolutionize surgery, while Flex's President, Randy Clark, highlights the impact of surgical robotics technology on patient care globally.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
14.29%
Tags
none
-
Rhea-AI Summary
Asensus Surgical, Inc. (NYSE American: ASXC) will release its 2023 third quarter financial and operating results on November 14, 2023, after the market closes. A conference call to discuss the results will take place at 4:30 p.m. ET on the same day, with a webcast available. Access details for the call and webcast are provided in the press release.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
Asensus Surgical, Inc. announced that Klinikum Idar-Oberstein Hospital in Germany has entered into a lease agreement to utilize a Senhance Surgical System. The collaboration aims to enhance patient outcomes through advanced minimally invasive surgery. The Senhance System, with its innovative features and established laparoscopic approach, is expected to bring valuable enhancements to the hospital.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.55%
Tags
none
Rhea-AI Summary
Asensus Surgical collaborates with NVIDIA to enhance the development of its Intelligent Surgical Unit (ISU) and improve clinical intelligence capabilities.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
24.14%
Tags
none
-
Rhea-AI Summary
Asensus Surgical, Inc. to participate in investment conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences
-
Rhea-AI Summary
Asensus Surgical partners with First Towakai Hospital in Japan to lease and utilize a Senhance Surgical System in their urology and gynecology centers and gastroenterology department.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.57%
Tags
none
Rhea-AI Summary
Asensus Surgical, Inc. announced its operating and financial results for the second quarter of 2023. Key highlights include a 27% YoY growth in surgical procedures, revenue of $1.1 million, and cash and cash equivalents of $40.0 million as of June 30, 2023. The company also completed a $10 million registered direct offering in July 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.03%
Tags
Asensus Surgical Inc

NYSE:ASXC

ASXC Rankings

ASXC Stock Data

70.99M
266.72M
1.97%
9.32%
6.53%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States
Durham

About ASXC

asensus aps is a computer software company based out of 22a vallensbækvej, brondby, capital region of denmark, denmark.